Skip to main content
An official website of the United States government

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

  • All Headings will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Resources

Staff List

Name, Email, Phone Room Group(s)/Office ID
LeeVan, Elyse, M.D., M.P.H.
elyse.leevan@nih.gov
240-276-7314
5E212 Program Officer | Early Detection 658
McCarty, Larae
larae.mccarty@nih.gov
240-276-5777
5E322 Program Specialist | Community Oncology and Prevention Trials
Early Detection
2611
Miller, Eric, Ph.D.
eric.miller2@nih.gov
240-276-5336
5E230 Program Officer | Early Detection 591
Ong, Mary Jane
maryjane.ong@nih.gov
240-858-3296
5E112 Nurse Consultant | Early Detection 2546
Pinsky, Paul, Ph.D.
paul.pinsky@nih.gov
240-276-7014
5E108 Chief | Early Detection 608
Saxena, Neeraj, Ph.D.
neeraj.saxena@nih.gov
240-276-6302
5E218 Program Officer | Early Detection 622
Zhu, Claire, Ph.D.
claire.zhu@nih.gov
240-276-7013
5E106 Program Officer | Early Detection 645

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Agsalda-Garcia, Melissa Anne

University Of Hawaii At Manoa
United States

Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients 1R21CA244078-01 Guillermo Marquez, Ph.D.
Ahn, Jiyoung

New York University School Of Medicine
United States

The Oral Mycobiome and Risk of Pancreatic Cancer 5U01CA250186-04 Claire Zhu, Ph.D.
Anderson, Garnet L.

Fred Hutchinson Cancer Center
United States

NCI Cancer Screening Research Network: Coordinating and Communication Center 3UG1CA286954-02S1 Elyse LeeVan, M.D., M.P.H.
Backman, Vadim

Northwestern University At Chicago
United States

Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification 1R01CA289294-01A1 Claire Zhu, Ph.D.
Badu-Tawiah, Abraham

Ohio State University
United States

Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening 5R21CA270727-02 Claire Zhu, Ph.D.
Bissonnette, Bruce Marc

University Of Chicago
United States

A non-invasive blood test for multi-cancer detection and determination of tissue of origin preceding overt cancer diagnosis 1U01CA297685-01 Claire Zhu, Ph.D.
Carlsson, Sigrid

Sloan-Kettering Inst Can Research
United States

Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers 5U01CA266535-03 Claire Zhu, Ph.D.
Chen, Ru

Baylor College Of Medicine
United States

BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION 1UH2CA292130-01 Claire Zhu, Ph.D.
Cook, Linda S

University Of Colorado Denver
United States

Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN) 5UG1CA286941-02 Elyse LeeVan, M.D., M.P.H.
Davis, Jennifer Sarah

University Of Kansas Medical Center
United States

Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype 7U01CA222163-04 Claire Zhu, Ph.D.
Demb, Joshua Brian

University Of California, San Diego
United States

Optimal early colorectal cancer screening initiation 4R00CA267181-03 Claire Zhu, Ph.D.
Doescher, Mark P

University Of Oklahoma Hlth Sciences Ctr
United States

Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub 3UG1CA287044-02S1 Elyse LeeVan, M.D., M.P.H.
Elmore, Joann G

University Of California Los Angeles
United States

Optimizing the Human-Computer Interaction in Pathology: Understanding the Impact of Computer-Aided Diagnosis Tools on Pathologists' Interpretive Performance 1R01CA288824-01A1 Claire Zhu, Ph.D.
Esserman, Laura J

University Of California, San Francisco
United States

Extending the Diversity, Reach, and Generalizability of the WISDOM Study 5R01CA237533-05 Claire Zhu, Ph.D.
Fahrmann, Johannes F

University Of Tx Md Anderson Can Ctr
United States

Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer 5U01CA282216-02 Claire Zhu, Ph.D.